Achieve Life Sciences prices $45M offering: 15M shares and warrants at $3.00 per unit

ACHIEVE LIFE SCIENCES, INC.

Public offering of 15M shares of common stock and accompanying warrants to purchase up to 15M shares, priced at $3.00 per unit.
Gross proceeds ~$45M; net proceeds ~$41.3M after underwriting discounts and expenses; expected close June 30, 2025.
Underwriters granted 30-day option to purchase up to an additional 2.25M shares and/or warrants.
Each warrant exercisable for one share at $3.00, or exchangeable for pre-funded warrant at $0.001/share; 5-year term; 9.99% ownership cap.
Proceeds to fund cytisinicline advancement for smoking cessation through potential FDA approval and for working capital.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.